- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
December 5, 2024Jake Holdreith Named to Twin Cities Business Top 100
-
December 4, 2024Robins Kaplan Obtains $10.5 Million Post-Verdict in Landmark Aerosol Dust Remover Abuse Case
-
December 2, 2024Robins Kaplan LLP Announces 2025 Partners
-
December 12, 2024Strategies for Licensing AI: A Litigation Perspective
-
December 11, 20242024 Year in Review: eDiscovery and Artificial Intelligence
-
December 4, 2024Trust & Estate Litigation in Minnesota
-
December 2024A Landmark Victory for Disabled Homeless Veterans: Q&A with the Trial Team
-
November 8, 2024Trademark tensions on the track: Court upholds First Amendment protections in Haas v. Steiner
-
November 8, 2024Destination Skiing And The DOJ's Mountain Merger Challenge
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Gene, Method Patent Rulings Said Top Issues for Life Sciences This Year
January 11, 2013
Reproduced with permission from Life Sciences Law & Industry Report, 7 LSLR 63 (Jan. 11, 2013). Copyright 2013 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com
Read the full article (PDF) with quotes from Sharon Roberg-Perez.
For 2013, much of the focus in the life sciences industry will be on patents, experts in life sciences predicted for BNA. Patentable subject matter in the United States and Europe, the scope of the patent infringement ‘‘safe harbor’’ provision, and ‘‘patent exhaustion’’ will be the top issues for 2013 as a result of the impact of past and anticipated court rulings, they said.
Life Sciences Law & Industry Report
Related Publications
November 8, 2024
Trademark tensions on the track: Court upholds First Amendment protections in Haas v. Steiner
David Martinez, Navin Ramalingam - Los Angeles & San Francisco Daily Journal
August 22, 2024
Prior Art Takeaways From Fed. Circ. Public Disclosure Ruling
Derrick Carman - Law360
August 13, 2024
Playing Dungeons & Dragons Makes Me A Better Lawyer
Derrick Carman - Law360
August 7, 2024
Making a Case for Trade Secret Misappropriation in the US
David Prange, Benjamen Linden and Demitri Dawson - IAM
July 24, 2024
Navigating Copyright Act Section 117 in Software Licensing and Litigation
Bryan Mechell, Zac Cohen - Westlaw Today
Related News
December 5, 2024
November 7, 2024
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.